1
QUANTITATIVE IN VIVO MAGNETIC RESONANCE IMAGING OF SPIO-LABELED CELLS IN A CERVICAL CANCER MOUSE MODEL Zoe O’Brien-Moran 1,2 , Marie-Laurence Tremblay 2 , Christa Davis 2 , James Rioux 1 , Kimberly D. Brewer 1,2 1 Dalhousie University; 2 Biomedical Translational Imaging Centre (BIOTIC) at IWK Health Centre & QEII Health Sciences Centre; Halifax, NS, Canada INTRODUCTION Background IMAGING METHODS GENERAL METHODS 1. Brewer KD et al. Clearance of depot vaccine SPIO-labeled antigen and substrate visualized using MRI. Vaccine 2014, 32:6956-6. 2. Rioux JA et al. Quantification of superparamagnetic iron oxide with large dynamic range using TurboSPI. Journal of Magnetic Resonance 2012, 216:152-60. 3. Majumdar S. et al. The influence of pulse sequence on the relaxation effects of superparamagnetic iron oxide contrast agents. Magnetic Resonance in Medicine, 1989, 102:289-301. 4. Rioux JA et al. 3D single point imaging with compressed sensing provides high temporal resolution R2* mapping for in vivo preclinical application. MAGMA 2016; epub ahead of print. IMAGING RESULTS v C57BL/6 mice are implanted with 5x10 5 C3 cells in 100 ul vCD8+ cells are isolated from disease matched GFP mice & cultured in vitro for 7 days v Cultured cells are loaded with ultra-small SPIO by passive incubation for 24 hours v Cells are delivered via tail vein injection 24 hours are given for initial cell migration v Mice are imaged according to the Imaging Methods protocol v Understanding the role of immune cells is in vivo is important for a number of disease processes, particularly with cancer and immunotherapies. v Magnetic resonance imaging (MRI) can be used to monitor immune cells in vivo by labeling with a superparamagnetic iron oxide (SPIO) contrast agent. v These methods allow us to detect immune cell recruitment and migration patterns by acquiring MRIs and analyzing changes in image contrast within a region of interest. v Traditionally, we have used a bSSFP MRI pulse sequence to perform studies evaluating SPIO labeled components 1 . Unfortunately, this sequence lacks specificity in detecting the contrast effects of SPIO. Labeled cells can be detected by an increase in negative (dark) contrast, but necrosis results in similar contrast. This was confirmed using simultaneous positron emission tomography (PET)/MRI (Fig. 1). v Additionally, the previous method does not support true quantitative evaluation of cellular recruitment. v We propose use of a second sequence, TurboSPI 2 , that has greater specificity and supports cellular quantification. IMAGE ANALYSIS RESULTS & DISCUSSION CONCLUSION FIGURE 1: Upper row: MRI obtained using bSSFP in sagittal (a), coronal (b), and axial (c) planes. Negative contrast in the center of the flank tumor suggests SPIO uptake or necrosis. Bottom row: 18F-FDG PET/MRI overlay in sagittal (d), axial (e), and coronal (f) planes using PET data obtained simultaneously with the MR data. A necrotic core is confirmed by low 18F-FDG activity aligned with the region of negative MR contrast. v SPIO nanoparticles have high magnetic susceptibility. They locally alter the magnetic field in the MRI scanner. The R 2 *(s -1 ) relaxation rates of protons near SPIO are increased. v All MRIs are obtained on a 3T pre-clinical Agilent (Menlo Park, CA, USA) scanner: v Balanced steady state free precession (bSSFP) is performed first for high- resolution anatomical images (TR/TE = 8/4 ms, α = 30°, 4 phase cycles, 4 averages, 256 x 170 x 170, FOV=38.4 mm x 25.5 mm x 25.5 mm, t=64min) v high signal to noise ratio (SNR) v high resolution v sensitive to SPIO effects 3 v TurboSPI is performed second (TR/TE effective = 250/10 ms, ETL=8, ESP=10ms, 96 x 96 x 48, FOV=30 mm x 30 mm x 30 mm, t=28min) v quantification capabilities v higher SPIO specificity v TurboSPI is a multi-echo single point imaging (SPI) sequence that is accelerated through compressed sensing techniques. R 2 * maps are calculated from TurboSPI data 4 . v PET data (Fig. 1) was obtained for several mice, using the NuPET (Cubresa, Winnipeg, MB, CA) insert for simultaneous PET/MR. QUANTIFICATION FIGURE 2: A summary schematic of the general method showing the steps from tumor implantation to imaging VERIFICATION v Immunohistochemistry was performed on the excised tumor to confirm the existence of injected (SPIO labeled) cells. Cells were labeled with DAPI (nuclear stain), and iron label has Rhodamine B attached. v The R 2 * mapping that is performed using TurboSPI offers more information than the bSSFP images. The specificity of the TurboSPI analysis results in more “true positive” regions and therefore more accurate evaluation of cellular recruitment. Furthermore, the R 2 * mapping and calibration provides superior cell quantification to previous techniques. We are currently evaluating the quantitative results of CD8+ T cell recruitment in a tumor model v We suggest that the imaging protocol for SPIO labeled cell tracking is most powerful when the two sequences, bSSFP and TurboSPI are used together, incorporating the strengths of each technique: the specificity and quantification from TurboSPI, and the resolution and SNR of bSSFP. v Parallel work is currently being performed using these cell tracking techniques to investigate the cellular response to different immunotherapy treatments (see poster by Tremblay et al.). CD8+ T cells and dendritic cells are being studied, particularly their response to immunotherapy, specifically a peptide-based vaccine, a checkpoint inhibitor and a combination of both therapies. FIGURE 3: Upper row: a) is the bSSFP MRI reconstructed in the axial plane, b) is an R 2 * map (pixel intensity in s -1 ) overlaid on the bSSFP slice that shows a distribution of R 2 * in the same plane. Region 1 indicates a pixel with a significant amount of iron in the tumor, Region 2 indicates signal from pure fat (oscillations are fat specific) and 3 suggests a combination of iron and fat. Bottom row: the MR signal time course for region 1 (c), region 2 (d), and region 3 (e) v After data acquisition, the under-sampled TurboSPI images were reconstructed using a supplemental guide image acquired immediately before the TurboSPI scan v R 2 * relaxation rate maps were calculated from the reconstructed multi-echo TurboSPI data. These maps are aligned with the axial slices of the bSSFP image and the set are analyzed in tandem. v Figure 3 shows an example image set using this technique. The R 2 * map in b) shows R 2 * value by pixel intensity. It is not an iron specific metric, but analyzing R 2 * value combined with the signal time course gives us information on iron content in regions of interest. v The time course of the signal in c) shows a voxel with suspected SPIO-labeled cells, d) shows a periodic time course from a fat voxel, e) shows a time course indicating the presence of both fat and iron from a voxel in the fat pad anterior to the tumor. v Interestingly, labeled CD8+ T cells seem to be primarily located at the tumor periphery, not in the central regions FIGURE 4: R 2 * calibration for different concentrations of SPIO loaded cells. v R 2 * calibration was performed for cellular quantification purposes & Samples were prepared with known cell concentrations and the bulk R 2 * was calculated using line width v Cellular concentrations are calculated from the voxel intensities in the R 2 * map and can be converted to numbers of cells/voxel using the voxel size v For example, the voxel indicated by region 1 in Figure 3 has approximately 540 cells/voxel Funding Provided by: IWK Student Scholarship (ZOBM), NSHRF Establishment Grant (KDB), IWK Category B grant (KDB), NSERC Discovery Grant (KDB), ACOA AIF (salary support KDB) FIGURE 4: a) DAPI stained cells in a tumor at week 4 b) Rhodamine B positive (i.e. SPIO- labeled) cells in the sectioned tumor 0 1000 2000 3000 4000 5000 Concentration (cell/mm 3 ) 240 260 280 300 320 340 R2* (s -1 ) R2* Calibration R2* = 0.018929c + 243.9122

QUANTITATIVE IN VIVO MAGNETIC RESONANCE IMAGING …...SPIO uptake or necrosis. Bottom row: 18F-FDG PET/MRI overlay in sagittal (d), axial (e), and coronal (f) planes using PET data

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: QUANTITATIVE IN VIVO MAGNETIC RESONANCE IMAGING …...SPIO uptake or necrosis. Bottom row: 18F-FDG PET/MRI overlay in sagittal (d), axial (e), and coronal (f) planes using PET data

QUANTITATIVE IN VIVO MAGNETIC RESONANCE IMAGING OF SPIO-LABELED CELLS IN A CERVICAL

CANCER MOUSE MODEL Zoe O’Brien-Moran1,2, Marie-Laurence Tremblay2, Christa Davis2, James Rioux1, Kimberly D. Brewer1,2

1Dalhousie University; 2 Biomedical Translational Imaging Centre (BIOTIC) at IWK Health Centre & QEII Health Sciences Centre; Halifax, NS, Canada

INTRODUCTION

Background

IMAGING METHODS

GENERAL METHODS

1.BrewerKDetal.ClearanceofdepotvaccineSPIO-labeledantigenandsubstratevisualizedusingMRI.Vaccine2014,32:6956-6.2.RiouxJAetal.QuantificationofsuperparamagneticironoxidewithlargedynamicrangeusingTurboSPI.JournalofMagneticResonance2012,216:152-60.3.MajumdarS.etal.Theinfluenceofpulsesequenceontherelaxationeffectsofsuperparamagneticironoxidecontrastagents.MagneticResonanceinMedicine,1989,102:289-301.4.RiouxJAetal.3DsinglepointimagingwithcompressedsensingprovideshightemporalresolutionR2*mappingforinvivopreclinicalapplication.MAGMA2016;epubaheadofprint.

IMAGING RESULTS

v  C57BL/6 miceareimplantedwith5x105C3cellsin100ulv CD8+ cells are isolated from diseasematchedGFPmice &cultured invitro for7daysv Culturedcellsare loadedwithultra-smallSPIObypassiveincubationfor24hoursv Cellsaredeliveredviatailveininjection24hoursaregivenforinitialcellmigrationv MiceareimagedaccordingtotheImagingMethodsprotocol

v  Understandingtheroleofimmunecellsis invivo isimportantforanumberofdiseaseprocesses,particularlywithcancerandimmunotherapies.

v  Magneticresonanceimaging(MRI)canbeusedtomonitorimmunecells invivobylabelingwithasuperparamagneticironoxide(SPIO)contrastagent.

v  Thesemethods allow us to detect immune cell recruitment andmigrationpatternsbyacquiringMRIsandanalyzingchangesinimagecontrastwithinaregionofinterest.

v  Traditionally,wehaveusedabSSFPMRIpulsesequencetoperformstudiesevaluating SPIO labeled components1. Unfortunately, this sequence lacksspecificity in detecting the contrast effects of SPIO. Labeled cells can bedetectedbyan increase innegative (dark) contrast,butnecrosis results insimilar contrast. Thiswas confirmed using simultaneous positron emissiontomography(PET)/MRI(Fig.1).

v  Additionally, the previous method does not support true quantitativeevaluationofcellularrecruitment.

v  Weproposeuseofasecondsequence,TurboSPI2,thathasgreaterspecificityandsupportscellularquantification.

IMAGE ANALYSIS

RESULTS & DISCUSSION

CONCLUSION

FIGURE1:Upperrow:MRIobtainedusingbSSFPinsagittal(a),coronal(b),andaxial (c) planes. Negative contrast in the center of the flank tumor suggestsSPIOuptakeornecrosis.Bottomrow: 18F-FDGPET/MRIoverlay insagittal (d),axial(e),andcoronal(f)planesusingPETdataobtainedsimultaneouslywiththeMRdata.Anecroticcoreisconfirmedbylow18F-FDGactivityalignedwiththeregionofnegativeMRcontrast.

v  SPIO nanoparticles have high magnetic susceptibility. They locally alter themagneticfieldintheMRIscanner.TheR2*(s-1)relaxationratesofprotonsnearSPIOareincreased.

v  All MRIs are obtained on a 3T pre-clinical Agilent (Menlo Park, CA, USA)scanner:

v  Balanced steady state free precession (bSSFP) is performed first for high-resolutionanatomicalimages(TR/TE=8/4ms,α=30°,4phasecycles,4averages,256x170x170,FOV=38.4mmx25.5mmx25.5mm,t=64min)

v  highsignaltonoiseratio(SNR)v  highresolutionv  sensitivetoSPIOeffects3

v  TurboSPI isperformedsecond(TR/TEeffective=250/10ms,ETL=8,ESP=10ms,96x96x48,FOV=30mmx30mmx30mm,t=28min)

v  quantificationcapabilitiesv  higherSPIOspecificity

v  TurboSPIisamulti-echosinglepointimaging(SPI)sequencethatisacceleratedthrough compressed sensing techniques. R2* maps are calculated fromTurboSPIdata4.

v  PET data (Fig. 1) was obtained for several mice, using the NuPET (Cubresa,Winnipeg,MB,CA)insertforsimultaneousPET/MR.

QUANTIFICATION

FIGURE2:Asummaryschematicofthegeneralmethodshowingthestepsfromtumorimplantationtoimaging

VERIFICATION v  Immunohistochemistry

was performed on thee x c i s e d t umo r t oconfirmtheexistenceofinjected (SPIO labeled)cells. Cellswere labeledwith DAPI (nuclearstain),andironlabelhasRhodamineBattached.

v  TheR2*mappingthatisperformedusingTurboSPIoffersmoreinformationthanthebSSFPimages.ThespecificityoftheTurboSPIanalysisresultsinmore“truepositive” regions and therefore more accurate evaluation of cellular recruitment. Furthermore, the R2* mapping and calibration provides superior cellquantificationtoprevioustechniques.WearecurrentlyevaluatingthequantitativeresultsofCD8+Tcellrecruitmentinatumormodel

v  We suggest that the imaging protocol for SPIO labeled cell tracking is most powerful when the two sequences, bSSFP and TurboSPI are used together,incorporatingthestrengthsofeachtechnique:thespecificityandquantificationfromTurboSPI,andtheresolutionandSNRofbSSFP.

v  Parallelworkiscurrentlybeingperformedusingthesecelltrackingtechniquestoinvestigatethecellularresponsetodifferentimmunotherapytreatments(seeposterbyTremblayetal.).CD8+Tcellsanddendriticcellsarebeingstudied,particularlytheirresponsetoimmunotherapy,specificallyapeptide-basedvaccine,acheckpointinhibitorandacombinationofboththerapies.

FIGURE3:Upperrow:a)isthebSSFPMRIreconstructedintheaxialplane,b)isan R2* map (pixel intensity in s-1) overlaid on the bSSFP slice that shows adistributionofR2*inthesameplane.Region1indicatesapixelwithasignificantamount of iron in the tumor, Region 2 indicates signal from pure fat(oscillations are fat specific) and 3 suggests a combination of iron and fat.Bottomrow:theMRsignaltimecourseforregion1(c),region2(d),andregion3(e)

v  After data acquisition, the under-sampled TurboSPI images were reconstructedusingasupplementalguideimageacquiredimmediatelybeforetheTurboSPIscan

v  R2* relaxation rate maps were calculated from the reconstructed multi-echoTurboSPIdata.ThesemapsarealignedwiththeaxialslicesofthebSSFPimageandthesetareanalyzedintandem.

v  Figure 3 shows an example image set using this technique. The R2* map in b)showsR2*valuebypixelintensity.Itisnotanironspecificmetric,butanalyzingR2*valuecombinedwiththesignaltimecoursegivesusinformationonironcontentinregionsofinterest.

v  Thetimecourseofthesignalinc)showsavoxelwithsuspectedSPIO-labeledcells,d)showsaperiodictimecoursefromafatvoxel,e)showsatimecourseindicatingthepresenceofbothfatandironfromavoxelinthefatpadanteriortothetumor.

v  Interestingly, labeled CD8+ T cells seem to be primarily located at the tumorperiphery,notinthecentralregions

FIGURE4:R2*calibrationfordifferentconcentrationsofSPIOloadedcells.

v  R2* calibration was performed forcellular quantification purposes &Samples were prepared with knowncell concentrations and the bulk R2*wascalculatedusinglinewidth

v  Cellular concentrations are calculatedfrom the voxel intensities in the R2*mapandcanbeconvertedtonumbersofcells/voxelusingthevoxelsize

v  For example, the voxel indicated byr e g i o n 1 i n F i g u r e 3 h a sapproximately540cells/voxel

FundingProvidedby:IWK Student Scholarship (ZOBM), NSHRF Establishment Grant (KDB),IWKCategoryBgrant(KDB),NSERCDiscoveryGrant(KDB),ACOAAIF(salarysupportKDB)

FIGURE 4: a) DAPI stained cells in a tumor atweek 4 b) Rhodamine B positive (i.e. SPIO-labeled)cellsinthesectionedtumor

0 1000 2000 3000 4000 5000Concentration (cell/mm 3)

240

260

280

300

320

340

R2*

(s-1

)

R2* CalibrationR2* = 0.018929c + 243.9122